BioCentury
ARTICLE | Financial News

UTHR gains as earnings top Street

July 30, 2014 1:12 AM UTC

United Therapeutics Corp. (NASDAQ:UTHR) gained $7.36 to $98.21 on Tuesday after reporting 2Q14 financial results that beat the Street. Diluted GAAP EPS in the quarter was $2.10, beating the Street's $...